Aim: Present study was elucidate the protective effect of pyridinone derivatives such as 7-amino-5-oxo-2-Phenyl-5H, 8H-dihydro- [1, 2, 4] triazolo [1, 5-α] pyridine -6-carbonitril (TRP 1) by in vitro, in vivo and in silico. Methods: Radioligand binding assay was performed on human adenosine receptors (A 2B ) and assess A 2B antagonist effect by adenylyl cyclase activity. In vitro study was carried out to determine the neutralize capacity against DPPH*, NO*, SO*, LPO* free radicals. TRP 1 at the doses 1 mg/ kg bd.wt. and 10 mg/kg bd.wt p.o, was administered consecutively for 14 days in albino rats. Ulcerative colitis was induced with single dose of 2 ml of 3% acetic acid intrarectal on 14 th day in treated rats. At the end of treatment, colonic tissue was collected and subjected for estimation of macroscopic score, glutathione, catalase, MPO and inflammatory parameters such as IL 1β, TNF α and IL 6. In silico study was carried out to evaluate the binding energy and IC 50 toward IL 1β, TNF α and IL 6. Results: TRP 1 was antagonized the A 2B receptors at the concentration of 30000 nM. In vitro study was revealed that TRP1 (1 mg/ml) was significantly neutralizes the free radicals of DPPH*, SO*, NO*and LPO*. In in vivo studies, intrarectal administration of acetic acid caused significantly (***P<0.001) increased macroscopic score, colon weight, colonic MPO, IL 6, IL 1β and TNF-α (*P<0.05), while TRP 1 treated colitis rats antioxidants system such as GSH (**P<0.01), catalase (*P<0.05) activity was significantly improved, decreases inflammatory mediators such TNF α (*P<0.05), IL 1β (**P<0.01) , IL 6 (**P< 0.01) and also suppresses the MPO activity (*P<0.05). In silico study was reported that the IC 50 of TPR 1 against IL 1β, IL 6 and TNF-α was 7.5 mM, 28.65 mM and 45.87 mM respectively. Conclusion: Our data demonstrated that the TRP 1 treatment improved clinical score in acetic acid induced colitis in rats. It also inhibited the proinflammatory cytokine IL-6, IL 1β and TNF α and improvements of antioxidant in colitis rats through A 2B receptor antagonist property.
INTRODUCTION
IBD, including Crohn's disease (CD) and ulcerative colitis (UC), is a lifelong disabling gastrointestinal disease.
1,2,3 Although etiology of inflammatory bowel disease (IBD) is unknown it appears that an abnormal 18-07-2017 response of the mucosal innate immune system to luminal bacteria may trigger inflammation which is perpetual by disregulation of cellular immunity 4, 5, 6 and imbalances between proinflammatory cytokines, such as TNF-α, IFN-γ, IL-1β, IL-6, and IL-12, and anti-inflammatory cytokines like IL-4, IL-10, IL-11. Therapeutic agents for IBD which include anti-inflammatory agents such as 5-aminosalicylates (5-ASA) and corticosteroids along with some immunomodulators like azathioprine, 6-mercaptopurine were used. However, treatments are associated with severe adverse events including diarrhea, cramps, abdominal pain accompanied by fever and high blood pressure. Thus, there is a need to develop new therapeutic options with low toxicity and minimal side effects. In the search for novel therapeutic options, increasing attention is being paid to the adenosine system and its involvement in the pathophysiology of IBDs. Extracellular adenosine binds to adenosine receptors (AR) 1, 2A, 2B and 3, all of which are expressed on the surface of immune cells. Low level expression of A 1 R is demonstrated in small intestine. A 2B R are highly expressed in the cecum and colon, esophagus, stomach, and jejunum but appears to be absent in the ileum.
7,8
Inflammatory mediators like TNFα, IL6 are increased in the intestinal mucosa, serum and stools of patients with IBD through up regulation and over expression of A 2B receptors. 9, 10, 11, 12, 13 Past scientific studies are supported that fused pyridinone ring derivatives have been found to versatile pharmacophore with wide range of useful biological activities due to antagonize adenosine receptors 14, 15 and ameliorated the inflammation. 16, 17, 18 Hence A 2B Rare great deal of interest, its primary molecular target and its mechanism of action remain to be clarified. In the present study was evaluated the protective effect of pyridinone derivatives like 7-amino-5-oxo-2-phenyl -5H,8H-dihydro-[1,2,4] triazolo [1,5-α] pyridine -6-carbonitril on colitis rats. Acetic acid induced colitis in rats is one of the common models in IBD research and resembles human ulcerative colitis in histology. 19, 20, 21, 22, 23 To test our hypothesis, the present study was undertaken to determine the possible mechanism of action of TRP 1 on the acetic acid induced ulcerative colitis in wistar rats.
MATERIALS AND METHODS

Materials
Adult male Wistar rats (200 -220 g) were purchased from Mahaveer enterprises, Hyderabad. 
Radioligand binding studies
The binding studies were conducted at Human A 2B following the reported procedure. 24 In brief, membranes for radioligand binding were prepared from CHO cells stably transfected with human Adenosine receptors subtypes in a two-step procedure. In a first low-speed step (1000 g), cell fragments and were removed. The crude membrane fraction was sedimented from the supernatant at 100000 g. The membrane pellet was resuspended in the buffer used for the respective binding experiments, frozen in liquid nitrogen and stored at -80 O C. For the measurement of adenylyl cyclase activity, only one high speed centrifugation of the homogenate was used. The resulting crude membrane pellet was resuspended in 50 mM Tris/ HCl, pH 7.4 and immediately used for the cyclase assay.
Adenylyl Cyclase Activity
The potency of antagonists at the A 2B R was determined in adenylyl cyclase experiments. The procedure was carried out as described previously with minor modifications. Membranes were incubated with about 150000 cpm of ATP for 20 min in the incubation mixture as described without EGTA and NaCl. For agonists, the EC 50 values for the stimulation of adenylyl cyclase were calculated with the Hill equation. Hill coefficients in all experiments were near unity. IC 50 value for concentration-dependent inhibition of NECA-stimulated adenylyl cyclase caused by antagonists was calculated accordingly. Dissociation constants (ki) for antagonists were calculated with the Cheng and Prusoff equation.
Antioxidant activity by in vitro
Antioxidant activity was tested by scavenging of DPPH* assay, 25 NO* assay, 26 SO* assay, 27 Fe +2 ascorbate induced lipid peroxidation assay.
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Anti-inflammatory activity by human RBC (HRBC) method 29 Blood was collected from the healthy volunteers and mixed with equal volume of sterilized Alsevers solution (composition Glucose 20.5 g, Sodium chloride 4.2, Tri-sodium citrate 8.0 g, and citric acid 0.55 g, distilled water 1000 mL). Blood solution was centrifuged at 3000 rpm and the packed cells were separated, then washed with isosaline (0.85%; P H 7.2) solution and a 10% v/v suspension was made with isosaline. This HRBC suspension was used for the estimation of anti-inflammatory property. Different concentrations of TRP1(100 ng/ml, 1 µg/ml, 10 µg/ml, 100 µg/ml and 1000 µg/ml), standard Sulfasalazine and control were separately mixed with 1ml of phosphate buffer (0.15 M, pH 7.4), 2mL of hyposaline (0.36%) and 0.5mL of HRBC suspension. All the assay mixtures were incubated at 37°c for 30 min and centrifuged at 3000 rpm. The supernatant liquid was decanted and the hemoglobin content was estimated by a spectrophotometer at 560 nm. The percentage hemolysis was estimated by assuring the hemolysis produced in the control as 100%. Instead of hyposaline 2 mL of distilled water was employed as control. The antiinflammatory potency was estimated by measuring % of inhibition of hemolysis Percentage inhibition of Hemolysis = [1-(ABS sample / ABS control )] × 100.
Acute toxicity
The acute oral toxicity was carried out as per the guidelines set by Organization for Economic Co-operation and Development (OECD), revised draft guidelines 423, received from Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Social Justice and Empowerment, Government of India.
Experimental procedure for the study the protective effect of TRP 1 on acetic acid induced ulcerative colitis
Animals were divided into five groups (n=6). In this study Sulfasalazine used as standard compound due to their potential anti-inflammatory activity against ulcerative colitis in rats and also used clinically.
30,31
Group I: Serve as sham control
Group II: Animals were pretreated with 80% DMSO for 14 th days and 2 ml of 3.0% acetic acid administered intra rectally on 14 th day Group III: Animals were pretreated with standard Sulfasalazine (360 mg/kg bd.wt.) for 14 days + 2 ml of 3.0% acetic acid administered intra rectally on 14 th day. Groups IV: Animals were pretreated with TRP 1 (1mg/kg bd.wt. dissolved in 80% DMSO) for 14 days + 2 ml of 3.0% acetic acid administered intrarectally on 14 th day. Groups V: Animals were pretreated with TRP 1 (10 mg/kg bd.wt.in 80% DMSO) for 14 day + 2 ml of 3.0% acetic acid administered intra rectally on 14 th day.
Assessments of colitis
Animals were scarified at the end of treatment, the distal 10 cm portions of the colon were removed and cut longitudinally, cleaned with physiological saline to remove fecal residues. Macroscopic inflammation scores are assigned based on the clinical features of the colon using an arbitrary scale ranging from 0 to10 as follows: 0 = No damage, 1 = Focal hyperemia (water oozes out), 2 = Ulcerization without hyperemia or bowel wall thickness, 3 = Ulcerization with inflammation at one site, 4 = Ulcerization with inflammation at two sites, 5 = Major sites of inflammation >1 cm along the organ with redness, 6 = Major sites of inflammation >2 cm along the organ with redness, 7 = Major sites of inflammation >3 cm along the organ with redness, 8 = Major sites of inflammation > 4 cm along the organ with redness, 9 = Major sites of inflammation >5 cm along the organ with redness and bleeding, and 10 = Major sites of inflammation >6 cm along the organ with redness, swelling, and bleeding.
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Biochemical assays
The colorectal tissue was collected, homogenized in 10 mM Tris-HCl buffer (p H 7.1). The homogenate was used for the measurement of antioxidant enzyme levels such as catalase, 33 glutathione, 34 colonic MPO activity,
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inflammatory cytokines such as TNF-α, IL-1β and IL-6 (Ray Biotech Inc., US) using standard sandwich enzymelinked immune sorbent assay (ELISA) kit specific for rat cytokines according to the manufacturer's instruction.
Histolopathological study
A portion (2 cm) of the colonic specimen from each rat (n= 6) was fixed in 10% formalin, cut into 5 μm thickness, stained using heamatoxylin-eosin and histopathological observations were made. The stained sections of colon were examined for any inflammatory changes like infiltration of the cells, necrotic foci and damage to tissue structures like payers patches, damage to nucleus.
In silico method
To evaluate the compound TRP 1 binding capacity by using AUTODOCK 4.2 version and the images are rendered using Accelry's Discovery studio vizualizer v4.0 interface.
Statistical analysis
All data values are expressed as mean ± SD. Statistical analyses were performed using a one-way analysis of variance (ANOVA) followed by Dunnett's test, using (Graph pad version 5.0) *P<0.05, **P<0.01, ***P<0.001 were considered as statistically significant.
RESULTS
Effect on human adenosine receptors
Compound TRP 1 exhibited inhibitory concentration toward A 2B receptors is 30,000 nM (Table 1) .
Effect on hemolysis
At the dose of 1000 µg/ml of TRP 1 exhibited 60.09±3.2% protection of HRBC in hypotonic solution ( Table 2 , Figure 1 ).
Effect on free radical scavenging activity
At the dose of 1 mg/ml of TRP 1 neutralize free radicals of DPPH (28.07±0.1%), SO (35.3±0.03%), NO (44.03±0.05%) and LPO (58±0.8%) all the results compared with Sulfasalazine (Table 3, Figure 2 ).
Acute toxicity
TRP 1 treated rats were safe upto the dose level 2000 mg/kg bd.wt. As per OECD guidance 423. At the dose level of 300 mg/kg bd.wt. And 2000 mg/kg bd.wt. Treated rats were exhibited drowsy. 
Effect on colon parameters in acetic acid induced colitis rats
At the end of the treatment, acetic acid administered rats exhibited severe macroscopic edematous inflammation in the colon. The inflammation score and weight of colon was significantly (***P<0.001) increased in colitis rats 8.3±0. , colonic GSH (6.9 ± 0.20; **P<0.01), the alteration in these biochemicals parameters when compared to colitis rats (Figure 3 and 4 ; Table 5 ).
Effect on cytokines TNF-α, IL-1β and IL-6 levels
Pro inflammatory cytokines are in acetic acid induced colitis rats showed significantly increased TNF-α (3800 ± 54.9; **P<0.01), IL 1β (5200 ±73.1; **P<0.01) and IL-6 (700 ± 90.4; **P<0.01) compared with those in the sham control group. TRP1 at the doses 1 mg/kg bd.wt. and 10 mg/kg bd. Wt., decreases the level of TNF-α from 3800 ± 54.9 pg/g tissue to 3200±22.8 pg/g, 3800 ± 54.9 pg/g tissue to 2900±22.6 pg/g (*P<0.05), respectively; correspondingly decrease of IL-1β from 5200±73.1 pg/g tissue to 4300±28.8 pg/g, 5200±73.1 pg/g tissue pg/mg to 3900±33.9 pg/mg tissue (**P<0.01), respectively. Correspondingly decrease of IL-6 from 700±90.4 pg/g tissue to 650±13.1 pg/g, 700±90.4 pg/g tissue pg/mg to 400±18.7 pg/mg tissue (**P<0.01), respectively (Table 5 , Figure 5 ).
Binding energy and inhibition of IL1-beta, IL6 and TNF-α by in silico
Docking is widely used in modern drug discovery process and effective tool for quickly and accurately predicting biomolecular conformation with binding energy of protein ligand complex. Compound TRP 1 exhibited potent inhibition on IL-1β (-6.7 Kcal/mol, 7.5 mM), TNF α (-5.92 Kcal/mol, 45.87 mM) and IL 6 (-6.2 Kcal/mol, 28.65 mM) ( Table 4 ). Acetic acid induced colitis showed massive necrotic destruction of epithelium, submucosal edema, areas of haemorrhages and inflammatory cellular infiltration. TRP 1 at low dose level showed minimal damage of the mucosa with slight submucosal edema and mild inflammatory cell infiltration. 10 mg/kg bd.wt. TRP 1 showed remarkable recovery of colonic mucosa from acetic acid induced colitis damage ( Figure 6 ).
DISCUSSION
Compound TRP 1 has been demonstrated to have protective effect against acetic acid induced ulcerative colitis. Adenosine plays prominent roles in maintaining tissue integrity by modulation of immune functions, down-regulation of phlogistic reactions, interference with the biosynthesis of proinflammatory cytokines and inhibition of neutrophil adhesion, degranulation and antioxidant activity. 36 A number of studies are reported that the adenosine agonists are trigger proinflammatory responses and neutrophile infiltration through stimulation of Adenosine receptors on neutrophils and lymphocytes. 37, 38, 39 Previous studies are revealed that upregulation of A 2B receptors are contributing in colitis pathology 40 which was attenuated by Adenosine receptor antagonists. 41, 42 In present study demonstrated that compound TRP 1 antagonize the A 2B receptors proved in radioligand binding studies and also exhibited antiinflammatory activity by in vitro. Oxidative stress plays an important role in pathophysiology of ulcerative colitis and there is direct evidence that generation of reactive oxygen species attack the cellular macromolecules, disrupt epithelial cell integrity. 43, 44 Acetic acid exerts damaging effect by an acute inflammatory response following colonic injury, accompanied by widespread hemorrhage, release of mediators, and formation of lesions. The protonated form of the acid liberates protons within the intracellular space, causing a massive intracellular acidification resulting in an immense epithelial damage. 45 The weight of the inflamed colonic tissue is considered as a reliable and sensitive indicator for the severity, extent of intestinal inflammation, over production of TNF α, IL-1β and IL-6 on intrarectal administration of acetic acid. 46, 47, 48, 49 Consistent with this notion, the results of this study revealed, acetic acid treated rats was showed significant increase colon weight and macroscopic damage score, indicative of formation of ulcers, edema and increases inflammatory cytokines levels such as TNF α, IL-1β and IL-6. Pretreatment with TRP 1 in acetic acid induced colitis significantly reduced the weight of inflamed colon weight, macroscopic damage compare with colitis rats and reverse elevated TNF α, IL-1β and IL-6 levels and prevent epithelial damage indicating its protective effect from ulcerative colitis. Indeed, the in vitro DPPH assay, Hydrogen peroxide scavenging assay, superoxide free radical scavenging assay, Fe 2+ ascorbate induced lipid peroxidation assay was performed to evaluate antioxidant potential of TRP 1, results indicated that compound to be endowed with free radical inhibitory activity. In silico studies also concluded that TRP 1 showed potent inhibition on IL1β, IL6 and TNF-α proteins. MPO is an enzyme present in neutrophil, the levels of MPO activity proportional to the neutrophil concentration inflamed tissue. Therefore measurement of MPO activity has been considered a sensitive assay for acute intestinal inflammation. In addition increased MPO activity has been reported to an index of neutrophil infiltration and inflammation 50 and also enzyme catalyzes the formation of potent cytotoxic oxidants such as hypochlorous acid from H 2 O 2 and chloride ions. 51, 52 MPO activity was increased by acute administration of acetic acid through rectal route 53 and its activity significantly reduces in TRP 1 treated colitis rats. Suppression of MPO activity by compound TRP 1 indicates inhibition of neutrophil infiltration in the colonic mucosa. GSH and catalase plays a vital role in protecting tissues against damage by scavenging oxidant products. Earlier studies revealed that GSH level has been reduced in tissues when antioxidant was neutralized by liberated oxygen derived free radicals. 54 Several studies are revealed that intrarectal administration of acetic acid to decreases antioxidant defensive system such as GSH and catalase activity. 23 Similarly current scientific study was observed increase in GSH and catalase activity in the compound TRP 1 treated colitis groups. Hence the results suggest that the defense system was improved by the treatment of TRP 1.
CONCLUSION
TRP 1 exhibited antagonist on A 2B receptors, possess anti-inflammatory activity and reduces inflammatory mediator's levels, enhanced antioxidant activity in acetic acid induced colitis in rats. All the above scientific evidence suggested that the selected compounds improve clinical score in acetic acid induced colitis rats.
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ABBREVIATION USED
TRP:
1-(7-amino-5-oxo-2-phenyl)-5H,8H-dihydro-[1,2,4] triazolo[1,5-α] pyridine -6-carbonitril),A 2B-Adenosine 2B; DPPH: 2,2-diphenyl-1-picrylhydrazyl; IBD: Inflammatory bowel disease; TNF: Tumor necrosis factor alpha; IL: Interleukins.
